(NASDAQ: LIN) Linde's forecast annual revenue growth rate of 3.56% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 2.88%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.9%.
Linde's revenue in 2025 is $33,245,000,000.On average, 6 Wall Street analysts forecast LIN's revenue for 2025 to be $15,872,050,756,786, with the lowest LIN revenue forecast at $15,726,377,445,937, and the highest LIN revenue forecast at $16,047,490,913,636. On average, 6 Wall Street analysts forecast LIN's revenue for 2026 to be $16,702,862,321,036, with the lowest LIN revenue forecast at $16,222,394,169,072, and the highest LIN revenue forecast at $16,974,993,967,932.
In 2027, LIN is forecast to generate $17,622,709,020,493 in revenue, with the lowest revenue forecast at $17,320,139,518,056 and the highest revenue forecast at $17,924,066,860,700.